Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models.
Break-through variants
Non-pharmaceutical interventions (NPIs)
Reinfection
Vaccination rate
Waning immunity
Journal
Infectious Disease Modelling
ISSN: 2468-0427
Titre abrégé: Infect Dis Model
Pays: China
ID NLM: 101692406
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
01
12
2021
revised:
07
02
2022
accepted:
24
02
2022
pubmed:
17
3
2022
medline:
17
3
2022
entrez:
16
3
2022
Statut:
ppublish
Résumé
Coronavirus Disease (COVID-19), which began as a small outbreak in Wuhan, China, in December 2019, became a global pandemic within months due to its high transmissibility. In the absence of pharmaceutical treatment, various non-pharmaceutical interventions (NPIs) to contain the spread of COVID-19 brought the entire world to a halt. After almost a year of seemingly returning to normalcy with the world's quickest vaccine development, the emergence of more infectious and vaccine resistant coronavirus variants is bringing the situation back to where it was a year ago. In the light of this new situation, we conducted a study to portray the possible scenarios based on the three key factors: impact of interventions (pharmaceutical and NPIs), vaccination rate, and vaccine efficacy. In our study, we assessed two of the most crucial factors, transmissibility and vaccination rate, in order to reduce the spreading of COVID-19 in a simple but effective manner. In order to incorporate the time-varying mutational landscape of COVID-19 variants, we estimated a weighted transmissibility composed of the proportion of existing strains that naturally vary over time. Additionally, we consider time varying vaccination rates based on the number of daily new cases. Our method for calculating the vaccination rate from past active cases is an effective approach in forecasting probable future scenarios as it actively tracks people's attitudes toward immunization as active case changes. Our simulations show that if a large number of individuals cannot be vaccinated by ensuring high efficacy in a short period of time, adopting NPIs is the best approach to manage disease transmission with the emergence of new vaccine breakthrough and more infectious variants.
Identifiants
pubmed: 35291223
doi: 10.1016/j.idm.2022.02.003
pii: S2468-0427(22)00007-0
pmc: PMC8913432
doi:
Types de publication
Journal Article
Langues
eng
Pagination
75-82Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.